Teja Turk

发表

Non-inferiority of simplified dolutegravir monotherapy compared to continued combination antiretroviral therapy that was initiated during primary HIV infection: a randomized, controlled, multi-site, open-label, non-inferiority trial Authors

K. Metzner, H. Günthard, H. Kuster, 2019 .

Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment.

V. Roth, J. Fellay, K. Metzner, 2020, Journal of acquired immune deficiency syndromes.

Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment

V. Roth, J. Fellay, K. Metzner, 2019 .

Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons

A. Trkola, R. Weber, M. Battegay, 2018, Open forum infectious diseases.

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

K. Metzner, Volker Roth, S. Parbhoo, 2019, Nature Communications.

HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection

K. Metzner, H. Günthard, P. Vernazza, 2020, Viruses.

Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection.

A. Trkola, J. Fellay, K. Metzner, 2019, The Journal of infectious diseases.

Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection

K. Metzner, H. Günthard, N. Beerenwinkel, 2019 .

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART

V. Roth, A. Trkola, J. Fellay, 2020, Nature Communications.